CVSCVS Health
- Employees
- 300,000
- Headquarters
- Woonsocket, RI
- CEO
- J. David Joyner
- Next results
- around Feb 9, 2027
What CVS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Facts only; most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans adopted or ended
No trading plans reported in 15 10-Qs and 10-Ks since May 3, 2023.
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 3, 2023.
Form 144 notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| May 22, 2026 | AGUIRRE FERNANDO Director |
32,000 | $3,030,080 | Compensation | none given | none found |
| May 21, 2026 | FARAH ROGER N Director |
2,817 | $263,886 | Compensation | none given | none found |
| May 8, 2026 | TILAK MANDADI Officer |
69,551 | $6,230,719 | Restricted Stock | none given | 69,551 shares from May 8, 2026 |
From the Form 144 XML filed with the SEC, since May 8, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Work on CVS in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/CVS/export.csv") into a cell.